By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six months before and after prostate surgery improved the chances of eliminating the ...

An expert on prostate cancer gives a brief overview of castrate-resistant prostate cancer. This is a synopsis of an Educated Patient Sound Bites series featuring Alicia Morgans, MD, MPH, of ...

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients. Just ...

Prostate cancer starts in the prostate, a small gland located below the bladder that is responsible for secreting one of the components of semen. Prostate cells may grow out of control and become ...

The addition of apalutamide to androgen deprivation therapy before and after surgery improved outcomes among men with ...

Researchers at Columbia University Irving Medical Center have identified a gene that drives the development of neuroendocrine ...

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients.

Ceramides-lipid molecules in cells that affect many physiological functions including cell differentiation, migration, and ...

A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than ...

Al Roker announced on TODAY that he has been diagnosed with prostate cancer and will be undergoing surgery to have his prostate removed. The 66-year-old TODAY weatherman and co-host explained he ...